Sreenivasa R. Chandana, Robin Kate Kelley, Richard S. Finn, Ecaterina Elena Dumbrava, Masafumi Ikeda, John Turner Hamm, Jaspreet Singh Grewal, Martin Gutierrez, Yuta Maruki, Takako Eguchi Nakajima, Tatsuki Ikoma, Maggie Weinstein, Sabeen Fatima Mekan, Ghassan K. Abou-Alfa. "A phase 1, first-in-human, multicenter study of ZW251, a novel glypican-3 (GPC3)–targeted antibody-drug conjugate (ADC), in participants with hepatocellular carcinoma (HCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps608